All of the above are demonstrated by this year’s recipients of the annual Canada Gairdner Awards, announced on Thursday by the Toronto-based Gairdner Foundation.

Among the eight awardees are researchers whose pioneering work produced an effective mode of cancer immune therapy, powered a revolution in DNA sequencing and led the charge against one of the world’s most prevalent childhood infections.

Established in 1957 with a donation from philanthropist James A. Gairdner, the awards have since become Canada’s most prestigious prize for breakthrough research conducted around the world in biomedical science.

To read the full article, please visit The Globe and Mail.